US 11,806,331 B2
Low dose therapeutic treatment
Perry Davidson, Tel-Aviv (IL); Seth Kindler, Tel-Aviv (IL); Shlomo Almog, Reut (IL); Binyamin Schwartz, Sde Eliezer (IL); Aaron Schorr, Doar-Na Misgav (IL); and Daniella Atzmony, Modiin-Maccabim-Reut (IL)
Assigned to Syqe Medical Ltd., Tel-Aviv (IL)
Appl. No. 16/068,373
Filed by Syqe Medical Ltd., Tel-Aviv (IL)
PCT Filed Jan. 5, 2017, PCT No. PCT/IL2017/050014
§ 371(c)(1), (2) Date Jul. 6, 2018,
PCT Pub. No. WO2017/118980, PCT Pub. Date Jul. 13, 2017.
Claims priority of provisional application 62/275,314, filed on Jan. 6, 2016.
Prior Publication US 2019/0015382 A1, Jan. 17, 2019
Int. Cl. A61M 11/00 (2006.01); A61K 31/352 (2006.01); A61K 9/00 (2006.01); A61M 15/00 (2006.01); A61M 11/04 (2006.01); G16H 20/13 (2018.01); A61P 29/02 (2006.01); G16H 40/63 (2018.01)
CPC A61K 31/352 (2013.01) [A61K 9/008 (2013.01); A61M 11/042 (2014.02); A61M 15/0003 (2014.02); A61M 15/009 (2013.01); A61P 29/02 (2018.01); G16H 20/13 (2018.01); G16H 40/63 (2018.01); A61M 2205/52 (2013.01)] 26 Claims
OG exemplary drawing
 
1. A system for delivering to a subject at least one pre-determined amount of THC, the system comprising:
a memory which stores a scheduled regimen for delivery of THC to said subject, said scheduled regimen administered over a total treatment period of a plurality of days, said scheduled regimen defining the delivery of a plurality of doses under the condition that a maximal amount of THC to be delivered in each of said plurality of doses is 2 mg or less, and a time period within which said amount of 2 mg or less is delivered is 2 hours or longer;
a decision module comprising circuitry configured to decide, according to said scheduled regimen, if a delivery should take place; and
an inhaler device for delivering said THC to said subject to thereby reduce at least one treated symptom without return of the symptom to a pre-inhalation degree for said time period of two hours or longer, said inhaler device comprising a controller which carries out delivery of said THC based on the decision made by said circuitry of said decision module; and
wherein said inhaler device is configured to lock for predefined periods of time which are set according to said scheduled regimen, preventing additional delivery such that said amount of 2 mg or less delivered over 2 hours or longer is not surpassed.